Exact Mass: 427.3032634

Exact Mass Matches: 427.3032634

Found 40 metabolites which its exact mass value is equals to given mass value 427.3032634, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-Linoleoyl Phenylalanine

2-(octadeca-9,12-dienamido)-3-phenylpropanoic acid

C27H41NO3 (427.3086276)


N-linoleoyl phenylalanine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Linoleic acid amide of Phenylalanine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Linoleoyl Phenylalanine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Linoleoyl Phenylalanine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Docosahexaenoyl Valine

2-(docosa-4,7,10,13,16,19-hexaenamido)-3-methylbutanoic acid

C27H41NO3 (427.3086276)


N-docosahexaenoyl valine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Valine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Valine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Valine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Peimisine

5-hydroxy-2,3,6,15-tetramethyl-3a,4,5,6,7,7a-hexahydro-3H-spiro[furo[3,2-b]pyridine-2,14-tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadecan]-15-en-8-one

C27H41NO3 (427.3086276)


   

Peimisine

Spiro[9H-benzo[a]fluorene-9,2(3H)-furo[3,2-b]pyridin]-5(6H)-one, 1,2,3,3a,4,4,4a,5,6,6a,6b,7,7,7a,8,11,11a,11b-octadecahydro-3-hydroxy-3,6,10,11b-tetramethyl-, (2R,3S,3R,3aS,4aS,6S,6aR,6bS,7aR,11aS,11bR)-

C27H41NO3 (427.3086276)


Peimisine is an alkaloid. Peimisine is a natural product found in Fritillaria anhuiensis, Fritillaria cirrhosa, and other organisms with data available. Peimisine (Ebeiensine) is a muscarinic M receptor antagonist and angiotensin converting enzyme (ACE) inhibitor. Peimisine shows anti-tumor, anti-inflammatory, antihypertensive activities. Peimisine can induce apoptosis and be used in cough and asthma research[1][2][3]. Peimisine (Ebeiensine) is a muscarinic M receptor antagonist and angiotensin converting enzyme (ACE) inhibitor. Peimisine shows anti-tumor, anti-inflammatory, antihypertensive activities. Peimisine can induce apoptosis and be used in cough and asthma research[1][2][3]. Peimisine (Ebeiensine) is a muscarinic M receptor antagonist and angiotensin converting enzyme (ACE) inhibitor. Peimisine shows anti-tumor, anti-inflammatory, antihypertensive activities. Peimisine can induce apoptosis and be used in cough and asthma research[1][2][3].

   
   

Peimisine

(3S,3R,3aS,4aS,6S,6aR,6bS,7aR,9R,11aS,11bR)-3-hydroxy-3,6,10,11b-tetramethyl-spiro[1,2,3,4,4a,6,6a,6b,7,8,11,11a-dodecahydrobenzo[a]fluorene-9,2-3a,4,5,6,7,7a-hexahydro-3H-furo[4,5-b]pyridine]-5-one

C27H41NO3 (427.3086276)


Peimisine (Ebeiensine) is a muscarinic M receptor antagonist and angiotensin converting enzyme (ACE) inhibitor. Peimisine shows anti-tumor, anti-inflammatory, antihypertensive activities. Peimisine can induce apoptosis and be used in cough and asthma research[1][2][3]. Peimisine (Ebeiensine) is a muscarinic M receptor antagonist and angiotensin converting enzyme (ACE) inhibitor. Peimisine shows anti-tumor, anti-inflammatory, antihypertensive activities. Peimisine can induce apoptosis and be used in cough and asthma research[1][2][3]. Peimisine (Ebeiensine) is a muscarinic M receptor antagonist and angiotensin converting enzyme (ACE) inhibitor. Peimisine shows anti-tumor, anti-inflammatory, antihypertensive activities. Peimisine can induce apoptosis and be used in cough and asthma research[1][2][3].

   
   

(3R*,4S*,5S*,6S*,8R*,10R*)-3-[1,2,4a,5,6,7,8,8a-octahydro-3,6,8-trimethyl-2-[(E)-1-methyl-1-propenyl]-1-naphthalenyl]carbonyl-5-butoxy-1,5-dihydro-5-methyl-2H-pyrrol-2-one|ascosalipyrrolidinone A

(3R*,4S*,5S*,6S*,8R*,10R*)-3-[1,2,4a,5,6,7,8,8a-octahydro-3,6,8-trimethyl-2-[(E)-1-methyl-1-propenyl]-1-naphthalenyl]carbonyl-5-butoxy-1,5-dihydro-5-methyl-2H-pyrrol-2-one|ascosalipyrrolidinone A

C27H41NO3 (427.3086276)


   

(25R)-23,26-epimino-3beta-hydroxy-5alpha-cholest-23(N)-ene-6,22-dione

(25R)-23,26-epimino-3beta-hydroxy-5alpha-cholest-23(N)-ene-6,22-dione

C27H41NO3 (427.3086276)


   
   
   
   

myceliothermophin C

myceliothermophin C

C27H41NO3 (427.3086276)


   

12beta-hydroxy-(25S)-22betaN-spirosol-4-en-3-one

12beta-hydroxy-(25S)-22betaN-spirosol-4-en-3-one

C27H41NO3 (427.3086276)


   
   

(23R)-17,23-epoxy-veratra-5,12-diene-3beta,11beta-diol|deoxojervin-11beta-ol|Servin-11beta-ol|Veratrobasin

(23R)-17,23-epoxy-veratra-5,12-diene-3beta,11beta-diol|deoxojervin-11beta-ol|Servin-11beta-ol|Veratrobasin

C27H41NO3 (427.3086276)


   

(20Xi,23Xi,25Xi,26Xi)-23,26-epoxy-3beta-hydroxy-(5alpha)-16,28-seco-solanid-22(28)-en-6-one|Korsevinin|korsevinine

(20Xi,23Xi,25Xi,26Xi)-23,26-epoxy-3beta-hydroxy-(5alpha)-16,28-seco-solanid-22(28)-en-6-one|Korsevinin|korsevinine

C27H41NO3 (427.3086276)


   

Brachystamide E|brachystamide-E|N-isobutyl-16-(3,4-methylenedioxyphenyl)-2E,4E-hexadecadienamide

Brachystamide E|brachystamide-E|N-isobutyl-16-(3,4-methylenedioxyphenyl)-2E,4E-hexadecadienamide

C27H41NO3 (427.3086276)


   

Sipeimone

Sipeimone

C27H41NO3 (427.3086276)


Origin: Plant; SubCategory_DNP: Steroidal alkaloids, Veratrum alkaloids

   

PGF2&alpha

N-[(2-hydroxy-1-hydroxymethyl)ethyl]-9α,11α,15S-trihydroxy-prosta-5Z,13E-dien-1-amide

C23H41NO6 (427.29337260000005)


   

PGF2alpha-dihydroxypropanylamine

N-(1,3-dihydroxypropan-2-yl)-9S,11R,15S-trihydroxy-5Z,13E-prostadienoyl amine

C23H41NO6 (427.29337260000005)


   

dioctyl hydrogen phosphate, compound with 2,2-iminodiethanol (1:1)

dioctyl hydrogen phosphate, compound with 2,2-iminodiethanol (1:1)

C20H46NO6P (427.30625860000004)


   

2-(tert-butylamino)ethyl 2-methylprop-2-enoate,butyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate

2-(tert-butylamino)ethyl 2-methylprop-2-enoate,butyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate

C23H41NO6 (427.29337260000005)


   

[4-[[(2S)-1-[[(2S)-2-acetamido-4-methylpentanoyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-oxopentyl]-(diaminomethylidene)azanium

[4-[[(2S)-1-[[(2S)-2-acetamido-4-methylpentanoyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-oxopentyl]-(diaminomethylidene)azanium

C20H39N6O4+ (427.3032634)


   

N-Linoleoyl Phenylalanine

N-Linoleoyl Phenylalanine

C27H41NO3 (427.3086276)


   

2-[[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-methylbutanoic acid

2-[[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-methylbutanoic acid

C27H41NO3 (427.3086276)


   
   

(2E)-18-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]octadec-2-enoate

(2E)-18-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]octadec-2-enoate

C24H43O6- (427.3059478)


   

(E,17R)-17-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyoctadec-2-enoate

(E,17R)-17-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyoctadec-2-enoate

C24H43O6- (427.3059478)


   

leupeptin(1+)

leupeptin(1+)

C20H39N6O4 (427.3032634)


A guanidinium ion that is the conjugate acid of leupeptin, arising from protonation of the guanidino group; major species at pH 7.3.

   

oscr#31(1-)

oscr#31(1-)

C24H43O6 (427.3059478)


A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#31, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

ascr#31(1-)

ascr#31(1-)

C24H43O6 (427.3059478)


Conjugate base of ascr#31

   
   

NA-PABA 20:2(11Z,14Z)

NA-PABA 20:2(11Z,14Z)

C27H41NO3 (427.3086276)


   

NA-Phe 18:2(9E,12E)

NA-Phe 18:2(9E,12E)

C27H41NO3 (427.3086276)


   

NA-Phe 18:2(9Z,12Z)

NA-Phe 18:2(9Z,12Z)

C27H41NO3 (427.3086276)


   

NA-Val 22:6(4Z,7Z,10Z,13Z,16Z,19Z)

NA-Val 22:6(4Z,7Z,10Z,13Z,16Z,19Z)

C27H41NO3 (427.3086276)